Komipharm, Foreigners Net Buy 9,416 Shares... Stock Price Up 0.85%

As of 12:31 PM on the 10th, Komipharm is trading at 17,850 KRW, up 0.85% from the previous day. This represents a 19.23% decline compared to May 14. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Today, foreigners are tentatively estimated to have net purchased 9,416 shares. Over the past five days, individual investors have net purchased 45,969 shares, while foreigners and institutions have net sold 64,793 shares and net purchased 13,227 shares, respectively.

On June 8, Komipharm was a market issue due to the "Korean Ministry of Food and Drug Safety's rejection of the COVID-19 treatment clinical trial," which caused a weak market reaction.

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.